Pericapsular nerve group block followed by regional anesthesia for pathological fracture fixation in a multiple myeloma patient.
Aayusha SuwalNischal SubediNischal ShresthaUjma ShresthaPublished in: Clinical case reports (2024)
Multiple myeloma is a malignant plasma cell disease that often presents with anemia, renal failure, hyperkalemia and osteolytic bone lesions. The advancements in drug therapy of multiple myeloma have prolonged the lifespan of the affected people, resulting in a rise in cases of surgical management of fractures in such patients. Anesthetic management, despite being of utmost importance in minimizing perioperative complications in such patients, has not been widely studied, especially in this part of the world. Hence, we report a case of 64 years diabetic, HbSAg positive male with hypothyroidism and a known case of multiple myeloma since the last 6 years, under medication for his comorbidities who suffered acetabular fracture. In this case report, the use of pericapsular nerve group block followed by spinal anesthesia for the operative management of the fracture has been discussed along with several pre- and postanesthetic considerations. With appropriate anesthetic techniques and proper pre- and postanesthetic care, better outcomes can be guaranteed.
Keyphrases
- multiple myeloma
- end stage renal disease
- case report
- chronic kidney disease
- newly diagnosed
- ejection fraction
- healthcare
- type diabetes
- peritoneal dialysis
- patients undergoing
- stem cells
- risk factors
- pain management
- single cell
- total knee arthroplasty
- mesenchymal stem cells
- adverse drug
- insulin resistance
- health insurance
- weight loss
- electronic health record
- glycemic control
- affordable care act
- drug induced